Hester Biosciences reports Rs. 8.48 crore consolidated profit in Q3FY22

Hester Biosciences Limited has reported Consolidated financial results for the period ended December 31, 2021.

Financial Results (Q3 FY2022) - QoQ Comparison

The company has reported total income of Rs. 58.466 crores during the period ended December 31, 2021 as compared to Rs. 64.086 crores during the period ended September 30, 2021.

The company has posted net profit / (loss) of Rs. 8.484 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 10.623 crores for the period ended September 30, 2021.

The company has reported EPS of Rs. 9.79 for the period ended December 31, 2021 as compared to Rs. 13.08 for the period ended September 30, 2021.

Financials	Q3 FY2022	Q2 FY2022	% Change
Total Income	₹ 58.466 crs	₹64.086 crs	-8.77%
Net Profit	₹8.484 crs	₹10.623 crs	-20.14%
EPS	₹9.79	₹13.08	-25.15%

Financial Results (Q3 FY2022) - YoY Comparison

The company has reported total income of Rs. 58.466 crores during the period ended December 31, 2021 as compared to Rs.58.165 crores during the period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.8.484 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.12.345 crores for the period ended December 31, 2020.

The company has reported EPS of Rs.9.79 for the period ended December 31, 2021 as compared to Rs.15.13 for the period ended December 31, 2020.

Financials	Q3 FY2022	Q3 FY2021	% Change
Total Income	₹ 58.466 crs	₹58.165 crs	0.52%
Net Profit	₹8.484 crs	₹12.345 crs	-31.28%
EPS	₹9.79	₹15.13	-35.29%

Financial Results (9 Months Ended FY2022) - YoY Comparison

The company has reported total income of Rs.185.086 crores during the 9 Months period ended December 31, 2021 as compared to Rs.152.365 crores during the 9 Months period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.31.597 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.24.742 crores for the 9 Months period ended December 31, 2020.

The company has reported EPS of Rs.35.83 for the 9 Months period ended December 31, 2021 as compared to Rs.28.92 for the 9 Months period ended December 31, 2020.

Financials	9 Months Ended FY2022	9 Months Ended FY2021	% Change
Total Income	₹185.086 crs	₹152.365 crs	21.48%
Net Profit	₹31.597 crs	₹24.742 crs	27.71%
EPS	₹35.83	₹28.92	23.89%

Shares of Hester Biosciences Limited was last trading in BSE at Rs. 2389.95 as compared to the previous close of Rs. 2394.40. The total number of shares traded during the day was 312 in over 113 trades.

The stock hit an intraday high of Rs. 2413.90 and intraday low of 2370.00. The net turnover during the day was Rs. 749209.00.

Source : Equity Bulls

Keywords

HesterBiosciences Q3FY22 9MFY22 ResultUpdate